Charles S. Dai

Targeting the Androgen Signaling Axis in Prostate Cancer.

S. Dehm, N. Sharifi, C. Dai, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Revisiting Androgen Receptor Signaling in Breast Cancer

L. Ellisen, C. Dai, Charles Dai, 2023, The oncologist.

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

W. Gradishar, R. Bose, A. Bardia, 2022, EBioMedicine.

Novel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer: elacestrant as the poster-child

S. Wander, A. Medford, J. Keenan, 2024, Expert review of anticancer therapy.

TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis

A. Bardia, J. Lennerz, L. Ellisen, 2023, Therapeutic advances in medical oncology.